Protocol
Study Status
Title
Principal Investigator
CTOTC-01
Closed
Immunosuppression Minimization to Single Drug Therapy with Sirolimus (Rapamune®) in Pediatric Transplantation
William Harmon, M.D.
CTOTC-02
Closed
Immune Development and Alloimmunity in Pediatric Renal Transplant Recipients
Allan Kirk, M.D., PhD.
CTOTC-03
Closed
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation
Stuart Sweet, M.D., PhD.
CTOTC-04
Closed
Pediatric Heart Transplantation Across a Positive Donor Specific Cross-Match
Steven Webber, M.D., PhD.
CTOTC-05
Closed
Perceived Barriers to Patient Adherence after Pediatric Solid Organ Transplantation
Stuart Sweet, M.D., PhD.
CTOTC-06
Closed
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Carlos Esquivel, MD, PhD
CTOTC-08
Closed
B Cell Targeted Induction to Improve Outcomes in Pediatric Lung Transplantation
Stuart Sweet, MD
CTOTC-09
Closed
An Observational Cohort Study to Determine the Impact of Donor-Specific HLA Antibodies (Pre-formed versus De Novo) and Antibodies to Self Antigens (Cardiac Myosin, Vimentin) on Chronic Graft Outcomes up to 5 years after Pediatric Heart Transplantation
Steven A Webber, MBChB, MRCP
CTOTC-10
Closed
Randomized Controlled Trial of Novel Mobile Device Application to Improve Adherence in Children >11 years of age After Cardiac Transplantation
Steven A Webber, MBChB, MRCP
CTOTC-11
Closed
Prevalence and Correlates of PTSS in Adolescent Solid Organ Transplant Recipients
Stuart Sweet, MD, PhD
CTOTC-12
Closed
Safety of Donor Alloantigen Reactive Tregs to Facilitate Minimization and/or Discontinuation of Immunosuppression in Adult Liver Transplant Recipients
Sandy Feng, MD, PhD
CTOTC-14
Closed
A Retrospective Multicenter Study to Determine Clinical Outcomes in Subjects Previously Enrolled in the CTOTC-03 Study
Stuart Sweet, MD, PhD
For User Access or issues with use of the site, please contact user support . Questions and comments, please contact the
webmaster .
© 2009 Rho, Inc. All rights reserved.